Fluorescent microsphere combined detection device for myocardial marker and preparation method thereof
A myocardial marker and combined detection technology, which can be used in measurement devices, biological tests, material testing products, etc., can solve the problems of easy quenching of fluorescent antibodies, weak binding force, and insufficient amount of protein adsorbed by NC membranes, and improve the sensitivity. , reduce the dosage, and improve the effect of reasonable comprehensive judgment
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0046] The sample pad 1, the immunofluorescent antibody glass fiber membrane 2, the nitrocellulose membrane 3, and the absorbent pad 4 are respectively pasted on the plastic plate 5, and the two ends of the nitrocellulose membrane 3 are connected to the absorbent pad 4, the immunofluorescent antibody glass fiber membrane, respectively. 2 overlapping, the other end of the immunofluorescence antibody glass fiber membrane 2 is overlapped with the sample pad 1; the first detection line T1, the second detection line T2, the third detection line T3 and the first detection line T1 are set on the nitrocellulose membrane 3 Quality control line C; the solid phase of the first detection line T1 has highly specific MPO antibodies, the solid phase of the second detection line T2 has highly specific cTnI or cTnT antibodies, and the third detection line There is a highly specific H-FABP antibody on the solid phase of T3, and there is a highly specific NT-proBNP antibody on the solid phase of ...
Embodiment 2
[0066] Preparation of polyethylene glycol glycerin treatment solution: mixed with polyethylene glycol glycerin and polylysine (SIGMA, 150KD), wherein the concentration of polyethylene glycol glycerin is 0.5%, and polylysine The concentration is 0.5%, filtered through a 0.22μm filter membrane, and set aside.
[0067] All the other are with embodiment 1.
Embodiment 3
[0069] Preparation of polyethylene glycol glycerin treatment solution: mixed with polyethylene glycol glycerin, polylysine (SIGMA, 150KD) and PEG2000, wherein the concentration of polyethylene glycol glycerin is 0.5%, poly The concentration of lysine is 0.5%, and the concentration of PEG20000 is 0.1%, and it is filtered through a 0.22 μm filter membrane for later use.
[0070] All the other are with embodiment 1.
[0071] Further illustrate the effect of the present invention by experiment below.
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


